Editorial : emerging markets' health and pharmaceutical sectors at the dawn of a potential global financial crisis of early 2020s

Jakovljevic, Mihajlo and Lamnisos, Demetris and Timofeyev, Yuriy and khan, Habib Nawaz and Ranabhat, Chhabi Lal and Godman, Brian (2022) Editorial : emerging markets' health and pharmaceutical sectors at the dawn of a potential global financial crisis of early 2020s. Frontiers in Pharmacology, 13. 907612. ISSN 1663-9812 (https://doi.org/10.3389/fphar.2022.907612)

[thumbnail of Jakovljevic-etal-FIP-2022-Emerging-markets-health-and-pharmaceutical]
Preview
 Text. Filename: Jakovljevic_etal_FIP_2022_Emerging_markets_health_and_pharmaceutical.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (574kB)| Preview

Abstract

Essential pharmaceutical innovation in terms of market placement of new chemical entities featuring medicines with novel mechanisms continue to be dominated by Pharmaceutical multinational companies (Sadat Russel et al, 2014). This is gradually changing with the growth of emerging biopharma companies launching their new products rather than being bought over by major Pharma Companies (IQVIA Report 2022).

CORE (COnnecting REpositories)